Tekla Healthcare Investors and Tekla Life Sciences Investors

Represented Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund, closed-end funds focused on investments in public and private healthcare companies, in connection with their investments in the Series C Preferred financing of Milestone Pharmaceuticals, Inc., a clinical stage cardiovascular company.